Login / Signup

CSF metabolomics alterations after aneurysmal subarachnoid hemorrhage: what do we know?

Wing Mann HoFranziska A SchmidtClaudius ThoméOndra Petr
Published in: Acta neurologica Belgica (2023)
There is increasing evidence suggesting that biomarkers can give insight in the pathogenesis and can serve as an outcome predictor. In this mini review, we present a brief overview of metabolomics profiling in neuroscience and wish to discuss the predictive and therapeutic value in aSAH patients.
Keyphrases
  • end stage renal disease
  • mass spectrometry
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • single cell